TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 66 filers reported holding TCR2 THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $50 | +51.5% | 33,116 | 0.0% | 0.00% | – |
| Q4 2022 | $33 | -99.9% | 33,116 | -1.3% | 0.00% | – |
| Q3 2022 | $60,000 | -41.7% | 33,561 | -5.5% | 0.00% | – |
| Q2 2022 | $103,000 | -7.2% | 35,525 | -12.2% | 0.00% | – |
| Q1 2022 | $111,000 | -75.8% | 40,477 | -58.8% | 0.00% | – |
| Q4 2021 | $458,000 | +63.0% | 98,142 | +197.1% | 0.00% | – |
| Q3 2021 | $281,000 | -59.5% | 33,032 | -21.8% | 0.00% | – |
| Q2 2021 | $694,000 | -35.6% | 42,235 | -13.4% | 0.00% | -100.0% |
| Q1 2021 | $1,077,000 | +205.1% | 48,779 | +326.6% | 0.00% | – |
| Q4 2020 | $353,000 | +16.1% | 11,435 | -23.7% | 0.00% | – |
| Q3 2020 | $304,000 | +120.3% | 14,996 | +67.2% | 0.00% | – |
| Q2 2020 | $138,000 | +360.0% | 8,969 | +130.4% | 0.00% | – |
| Q1 2020 | $30,000 | -82.2% | 3,893 | -67.2% | 0.00% | – |
| Q4 2019 | $169,000 | +89.9% | 11,885 | +102.0% | 0.00% | – |
| Q3 2019 | $89,000 | +456.2% | 5,885 | +402.1% | 0.00% | – |
| Q2 2019 | $16,000 | -60.0% | 1,172 | -49.4% | 0.00% | – |
| Q1 2019 | $40,000 | – | 2,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $62,221,000 | 18.51% |
| MPM BioImpact LLC | 3,370,982 | $51,778,000 | 13.77% |
| Redmile Group, LLC | 1,765,188 | $27,113,000 | 0.50% |
| ArrowMark Colorado Holdings LLC | 1,356,010 | $20,828,000 | 0.22% |
| DAFNA Capital Management LLC | 46,183 | $709,000 | 0.20% |
| Artal Group S.A. | 350,000 | $5,376,000 | 0.15% |
| WFA of San Diego, LLC | 4,733 | $540,000 | 0.13% |
| Granite Point Capital Management, L.P. | 100,000 | $1,536,000 | 0.08% |
| HHLR ADVISORS, LTD. | 322,903 | $4,960,000 | 0.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 30,000 | $461,000 | 0.04% |